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Abstract 36 
Studies on endocrine disruption in Australia have mainly focused on wastewater effluents. 37 
Limited knowledge exists regarding the relative contribution of different potential sources of 38 
endocrine active compounds (EACs) to the aquatic environment (e.g., pesticide run-off, 39 
animal farming operations, urban stormwater, industrial inputs). In this study, 73 river sites 40 
across mainland Australia were sampled quarterly for one year. Concentrations of 14 known 41 
EACs including natural and synthetic hormones and industrial compounds were quantified by 42 
chemical analysis. EACs were present in 88% of samples (250 of 285). Bisphenol A was the 43 
most frequently detected EAC (66%) and it’s predicted no-effect concentration (PNEC) was 44 
exceeded 24 times. The most common hormone was estrone, present in 28% of samples, and 45 
the PNEC was also exceeded 24 times. Ethinylestradiol was detected in 10% of samples at 46 
concentrations ranging from 0.05 - 0.17 ng/L. It was detected in many samples with no 47 
wastewater influence, and the PNEC was exceeded 13 times. In parallel to the chemical 48 
analysis, endocrine activity was assessed using a battery of CALUX bioassays. Estrogenic 49 
activity was detected in 19% (53 of 285) of samples (LOQ=0.1 ng/L 17β-estradiol equivalent; 50 
EEQ). Seven samples had estrogenic activity (1 - 6.5 ng/L EEQ) greater than the PNEC for 51 
17β-estradiol. Anti-progestagenic activity was detected in 16% of samples (LOQ=8 ng/L 52 
mifepristone equivalents; MifEQ), although the causative compounds remain unknown. With 53 
several compounds and endocrine activity exceeding PNEC values, there is potential hazard 54 
to the Australian freshwater environment. 55 
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1. Introduction 60 
Since the early 1980s, there has been increasing evidence that endocrine active compounds 61 
(EACs) negatively affect fish reproduction and pose a risk to ecological and human health 62 
(McLachlan et al. 1984; WHO/IPCS 2002). The first evidence of endocrine disruption in the 63 
aquatic environment was reported in the 1980s, when masculinized female mosquitofish 64 
(Gambusia holbrooki) were identified up to 6.5 km downstream of a pulp mill effluent 65 
discharge (Howell et al. 1980). Additional research has since demonstrated that endocrine 66 
disruption in aquatic environments is a widespread problem (Campbell et al. 2006; Jobling et 67 
al. 1998; Sumpter 2005; WHO/IPCS 2002) and often associated with chemicals present in 68 
municipal and industrial wastewater discharges.  69 
The first evidence of endocrine disruption in Australian rivers was reported in 1999 when 70 
male mosquitofish captured downstream of a wastewater treatment plant (WWTP) in the 71 
Greater Sydney area were shown to exhibit significantly reduced gonopodium length (a 72 
common biomarker of exposure to estrogenic and/or anti-androgenic EACs) compared with 73 
male fish captured at a reference site (Batty and Lim 1999). Follow-up laboratory studies 74 
demonstrated significantly decreased gonopodium length and reduced sexual activity after 75 
exposure to estrogenic EACs (Doyle and Lim 2002, 2005). Mosquitofish have since been 76 
used as bioindicators of EAC exposure in other Australian studies, with varying results. Some 77 
studies have reported no significant estrogenic effects in male mosquitofish exposed to 78 
domestic secondary treated wastewater but a possible minor androgenic effect resulting in 79 
slight elongation of female anal fins (Leusch et al. 2006a), while other studies have found 80 
significant reduction in gonopodium length consistent with estrogenic exposure in a lake 81 
impacted by urban and agricultural activities (Game et al. 2006). 82 
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Endocrine disruption research in Australia has largely focused on WWTP effluent discharges 83 
using chemical and, more recently, in vitro bioassay methods. As with the mosquitofish 84 
studies, those studies have yielded mixed results. Depending on the level of treatment, 85 
estrogenic EACs are sometimes detected in WWTP effluent at low ppt concentrations 86 
comparable to those found in other developed countries (Table 1). The handful of studies that 87 
have analysed river water samples have also detected low concentrations of estrogenic EACs  88 
(Chinathamby et al. 2013; Leusch et al. 2010; Tan et al. 2007; Williams et al. 2007; Ying et al. 89 
2009, 2008; Table 1). Whether in Australia or worldwide, most studies to date have measured 90 
in vitro estrogenic activity and, occasionally, androgenic activity, but almost none have 91 
measured anti-estrogenic, anti-androgenic, or (anti)progestagenic activity (GWRC 2012). 92 
There is significant cross-talk between endocrine axes, and a recent study indicated that anti-93 
androgens may be as important as estrogens to endocrine disruption in the aquatic 94 
environment (Jobling et al. 2009). The level of non-estrogenic endocrine activity in 95 
Australian rivers is currently unknown.  96 
To date, the Australian literature on endocrine disruption in the aquatic environment 97 
associated with WWTP effluent discharges emphasizes the need for more comprehensive 98 
studies (Williams et al. 2007). In particular, there is a need to understand the relative 99 
contribution of non-wastewater sources, such as industrial and agricultural inputs. A review 100 
on agricultural feedlot wastes (Khan et al. 2008) stressed the need for additional research on 101 
dairy shed effluents, which can be a significant source of steroidal input into aquatic 102 
environments (Matthiessen et al. 2006). The very few studies in this area suggest that dairy 103 
operations may be significant sources of steroid hormones in Australian rivers (Williams et al. 104 
2007; Table 1), and shortened gonopodia in male mosquitofish collected at agricultural and 105 
urban sites in Western Australia (Game et al. 2006) suggest that there may well be non-106 
wastewater sources of EACs in Australian rivers.  107 
This study aims to 1) assess multiple classes of EACs by measuring the (anti)estrogenic, 108 
(anti)androgenic and (anti)progestagenic activity in Australian rivers using in vitro bioassays; 109 
2) identify and quantify known EACs such as steroid hormones and industrial compounds by 110 
 5 
trace chemical analysis; and 3) to identify possible trends of EAC concentrations across 111 
mainland Australia using the data obtained in the first two objectives, focusing specifically on 112 
agricultural, industrial, residential, and wastewater-receiving sites.113 
 6 
Table 1. Hormone concentrations and estrogenic and androgenic activity reported in Australian studies. For a review of estrogenic activity in surface waters 114 
and effluents in other countries, see Jarosova et al. 2013, Kostich et al. 2013, Loos et al. 2013, Duong et al. 2010, and Jobling et al. 2006. LOD=limit of 115 
detection. EEQ = 17β-Estradiol equivalents. TMXEQ = Tamoxifen equivalents. TEQ = Testosterone equivalents. DHTEQ = Dihydrotestosterone equivalents. FluEQ = 116 
Flutamide equivalents. LevoEQ = Levonorgestrel equivalents. ACT = Australia Capital Territory. QLD = Queensland. SA = South Australia. NSW = New South Wales. VIC 117 
= Victoria. WA = Western Australia.  118 
 119 
Matrix Type State(s) Chemical results Bioassay results Reference(s) 
Estrogenic           
Effluent 1 WWTP QLD <1 ng/L 17β-estradiol;  Chapman 2003 
<1.5 ng/L estrone 
Effluent 2 WWTPs NSW <0.1 - 14 ng/L 17β-estradiol;   Braga et al. 2005a,b 
<0.1 - 54 ng/L estrone; 
<5 ng/L 17α-ethinylestradiol 
Effluent 1 WWTP QLD  <0.75 ng/L EEQ (E-SCREEN) Leusch et al. 2005 
Effluent 7 WWTPs VIC  <LOD - 55 ng/L EEQ (medaka 
ERBA) 
Mispagel et al. 2005 
Effluent 15 WWTPs QLD  <1 - 4.2 ng/L EEQ (ERBA) Leusch et al. 2006b 
Effluent 5 WWTPs (grab samples) QLD <LOQ estriol; 1.0 - 67.8 ng/L EEQ (E- Tan et al. 2007 
 7 
<1 - 41.9 ng/L estrone; SCREEN) 
<1 - 1.7 ng/L 17α-estradiol; 
<1 - 1.6 ng/L 17β-estradiol; 
11.6 - 86.7 ng/L bisphenol A; 
56.7 - 335.0 ng/L 4-nonylphenol; 
5.4 - 23.5 ng/L 4-t-octylphenol 
Effluent 11 WWTPs ACT, QLD, 
SA 
<0.05 - 6.35 ng/L 17β-estradiol; 0.03 - 1.96 ng/L EEQ (YES) Williams et al. 2007 
3.14 - 39.3 ng/L estrone;  
<0.05 - 1.30 ng/L 17α-ethinylestradiol;  
<10 - 148 ng/L bisphenol A;  
320 - 2,991 ng/L 4-nonylphenol;  
11 - 165 ng/L 4-t-octylphenol  
Effluent 4 WWTPs NSW  <0.02 - 0.3 ng/L EEQ (YES) Coleman et al. 2008 
Effluent 4 WWTPs SA 1.0 - 4.2 ng/L 17β-estradiol;  Ying et al. 2008 
13.3 - 39.3 ng/L estrone; 
0.1 - 1.3 ng/L 17α-ethinylestradiol; 
12 - 148 ng/L bisphenol A; 
860 - 2,887 ng/L 4-nonylphenol; 
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12 - 66 ng/L 4-t-octylphenol 
Effluent 13 WWTPs VIC 2 - 18 ng/L 17β-estradiol 1 - 10 ng/L EEQ (Y2H with the 
hERα) 
Mispagel et al. 2009 
Effluent 5 WWTPs QLD 1.37 - 6.35 ng/L 17β-estradiol; 6.34 - 22.61 ng/L EEQ 
(calculated using relative 
potencies derived with the YES 
assay) 
Ying et al. 2009 
9.12 - 32.22 ng/L estrone; 
0.11 - 1.20 ng/L 17α-ethinylestradiol; 
13 - 44 ng/L bisphenol A; 
614 - 2,991 ng/L 4-nonylphenol; 
17 - 165 ng/L 4-t-octylphenol 
Effluent 45 WWTPs VIC <0.05 - 19 ng/L 17β-estradiol; <0.1 - 73 ng/L EEQ (Y2H) Allinson et al. 2010 
<0.1 - 18 ng/L estrone; 
<0.002 - 0.6 ng/L 17α-ethinylestradiol 
Effluent 2 WWTPs QLD <5 ng/L 17β-estradiol; 0.8 - 8 ng/L EEQ (ER-CALUX) Leusch et al. 2010 
<5 ng/L estriol; 0.14 - 0.15 ng/L EEQ (E-
SCREEN) 
<5 - 23 ng/L estrone;  
<5 ng/L 17α-ethinylestradiol  
<25 - 50 ng/L bisphenol A;  
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338 - 1,120 ng/L 4-nonylphenol;  
233 - 500 ng/L 4-t-octylphenol  
Effluent 9 WWTPs VIC  <0.1 ng/L EEQ (hERα) Allinson et al. 2011 
Effluent 9 WWTPs Not specified <1 ng/L 17α-estradiol; <0.05 - 5 ng/L EEQ (ER-
CALUX) 
Leusch et al. 2014a  
<1 ng/L 17β-estradiol; 
<5 ng/L estriol; 
<1 - 20 ng/L estrone; 
<1 ng/L 17α-ethinylestradiol; 
<70 - 248 ng/L bisphenol A; 
<10 - 80 ng/L 4t-OP 
Effluent 4 WWTPs WA <5 ng/ L 17α-estradiol; <0.02 - 6 ng/L EEQ (E-SCREEN) Leusch et al. 2014b  
<5 ng/L 17β-estradiol; 
<50 - 170 ng/L estriol; 
<5 – 100 ng/L estrone; 
<5 ng/L 17α-ethinylestradiol 
River 11 Agricultural sites 
(dairy, grazing, 
horticulture) 
ACT, QLD, 
SA 
0.81 - 3.81 ng/L 17β-estradiol; 0.14 - 1.35 ng/L EEQ (ER-
CALUX); 
Williams et al. 2007 
1.47 - 13.79 ng/L estrone <0.3 - 1.22 ng/L EEQ (YES) 
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River 2 National parks SA 0.52 - 4.3 ng/L 17β-estradiol;  0.13 - 0.50 ng/L EEQ (ER-
CALUX); 
Williams et al. 2007 
0.17 - 4.2 ng/L estrone <0.3 ng/L ng/L EEQ (YES) 
River 1 Small and 1 large river QLD <5 ng/L 17β-estradiol; 0.15 – 0.5 ng/L EEQ (ER-
CALUX); 
Leusch et al. 2010 
<5 ng/L estriol; <0.02 - 0.4 ng/L EEQ (E-
SCREEN) 
<5 - 7 ng/L estrone;  
<5 ng/L 17α-ethinylestradiol;  
<25 ng/L bisphenol A;  
221 - 5,270 ng/L 4-nonylphenol;  
367 - 483 ng/L 4-t-octylphenol  
River 1 Residential SA 2.9 ng/L 17β-estradiol; 0.19 ng/L EEQ (ER-CALUX); Williams et al. 2007 
6.1 ng/L estrone 0.04 ng/L EEQ (YES) 
River 1 WWTP (grab sample) QLD <LOQ estriol; <0.1 ng/L EEQ (E-SCREEN) Tan et al. 2007 
1.5 ng/L estrone; 
<1 ng/L 17α-estradiol; 
7.3 ng/L 17β-estradiol; 
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5.5 ng/L bisphenol A; 
47.9 ng/L 4-nonylphenol; 
1.3 ng/L 4-t-octylphenol 
River 5 WWTPs SA 1.0 - 4.2 ng/L 17β-estradiol;  Ying et al. 2008 
13.3 - 39.3 ng/L estrone; 
0.1 - 1.3 ng/L 17α-ethinylestradiol; 
12 - 148 ng/L bisphenol A; 
860 - 2,887 ng/L 4-nonylphenol; 
12 - 66 ng/L 4-t-octylphenol 
River 5 WWTPs QLD 0.55 - 3.8 ng/L 17β-estradiol; 1.32 - 11.79 ng/L EEQ 
(calculated using relative 
potencies derived with the YES 
assay) 
Ying et al. 2009 
 1.25 - 14.5 ng/L estrone; 
<LOQ - 0.51 ng/L 17α-ethinylestradiol; 
10 - 59 ng/L bisphenol A; 
375 - 1,520 ng/L 4-nonylphenol; 
18 - 46 ng/L 4-t-octylphenol 
River 1 WWTP VIC  <0.3 - 12 ng/L EEQ (Y2H) Chinathamby et al. 
2013 
Anti-estrogenic     
 12 
Effluent 9 WWTPs Not specified  <2 µg/L TMXEQ (ER-CALUX) Leusch et al. 2014a  
Androgenic      
Effluent 15 WWTPs QLD  <6.5 - 736 ng/L TEQ (ARBA) Leusch et al. 2006b 
Effluent 5 WWTPs (grab samples) QLD <LOQ - 26.4 ng/L androsterone;  Tan et al. 2007 
<1 - 11.2 ng/L etiocholanolone 
Effluent 45 WWTPs VIC <LOD - 14.65 ng/L androstenedione; <LOD (hAR) Allinson et al. 2008 
   <LOD - 2.90 ng/L testosterone   
Effluent 4 WWTPs NSW  <0.1 - 8.9 ng/L TEQ (YAS) Coleman et al. 2008 
Effluent 9 WWTPs Not specified <5 ng/L dihydrogentestosterione; <2 - 2 ng/L DHTEQ (AR-
CALUX) 
Leusch et al. 2014a 
  <5 ng/L testosterone 
Effluent 4 WWTPs WA <1 - 17 ng/L androstenedione; <2.5 ng/L DHTEQ (AR-CALUX) Leusch et al. 2014b  
<50 - 67 ng/L androsterone; 
<50 ng/L dihydrotestosterone 
<100 - 180 ng/L etiocholanolone; 
<1 - 2.4 ng/L testosterone 
River 1 WWTP (grab sample) QLD <LOQ androsterone;  Tan et al. 2007 
<1 ng/L etiocholanolone 
Anti-androgenic     
 13 
Effluent 9 WWTPs Not specified <5 ng/L mestranol <25 µg/L FluEQ (AR-CALUX) Leusch et al. 2014a 
Progestagenic      
Effluent 9 WWTPs Not specified <5 ng/L levonorgestrel <0.01 - 5.4 ng/L LevoEQ (PR-
CALUX) 
Leusch et al. 2014a 
 120 
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2. Experimental Section 121 
2.1. Chemicals 122 
Solvents were analytical reagent grade. Acetone, hexane, methanol and hydrochloric acid 123 
(HCl) were provided by Merk (Victoria). Dihydrotestosterone (DHT; >99%), 17β-estradiol 124 
(98%), flutamide, levonorgestrel (>99%), mifepristone (>99%), tamoxifen (>99%), 125 
ethylenediaminetetraacetic acid (EDTA; >99%) and sodium hydroxide (>98%) were provided 126 
by Sigma-Aldrich (New South Wales). All cell culture reagents were purchased from Life 127 
Technologies (Victoria). Luciferin was sourced from P.J.K. (Kleinblittersdorf, Germany). 128 
 129 
2.2. Site selection 130 
A total of 73 sites were sampled: 19 each in the states of New South Wales (NSW), 131 
Queensland (QLD), and Victoria (VIC), 10 in Western Australia (WA), and three each in the 132 
Northern Territory (NT) and South Australia (SA) (Fig. 1). Sites were categorized based on 133 
the nearest major catchment land-use to the sampling location, but it is important to note that 134 
the majority of sample locations were adjacent or downstream of multiple land-use impacts, 135 
and simple categorization was generally not possible. Rivers in catchments with agricultural, 136 
industrial and residential activity as well as rivers receiving WWTP effluents were chosen, 137 
along with sites in catchments with less anthropogenic influences (i.e., “undeveloped” or 138 
“reference” sites) from each state/territory (Table 2). Sites were selected following extensive 139 
consultation with researchers, regulators and water industry partners familiar with the 140 
catchments. The goal was to identify a mix of catchment land-use types in every state. 141 
 142 
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Fig. 1. Location of sampling sites across mainland Australia. State and territory capitals are 143 
depicted by white diamonds, while black circles represent sampling locations. 144 
 145 
 146 
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Table 2. Number of samples sorted by land-use and sampling event. A catchment assessment 147 
was used to determine the nearest major land-use. WWTP = wastewater treatment plant. 148 
 149 
  Sample Event 
Nearest major 
land-use 
Fall 
(May 2011) 
Winter 
(Aug 2011) 
Spring 
(Nov 2011) 
Summer 
(Feb 2012) 
Agricultural 20 20 20 20 
Industrial 7 7 7 7 
Residential 19 19 18 18 
WWTP 13 13 12 12 
Reference 14 14 12 13 
Total 73 73 69 70 
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2.3. Water sampling 150 
Samples were collected quarterly from each site (with the exception of NT sites, where 151 
samples were collected biannually) over a one-year period. Samples were obtained in autumn 152 
(May 2011), winter (Aug 2011), spring (Nov 2011), and summer (Feb 2012) (Table 2). Two 153 
acetone-rinsed 1 L amber glass bottles were submerged approximately 30 cm below the water 154 
surface in order to collect the 2 L water sample required. To prevent biodegradation, the pH 155 
of each water sample was immediately adjusted to approximately pH 2 by addition of 1.5 mL 156 
of concentrated HCl (12 M). Basic water chemistry parameters (dissolved oxygen, electric 157 
conductivity, pH, temperature) were recorded prior to pH adjustment. Samples were then 158 
packaged with frozen ice blocks and sent by overnight courier to the laboratory for solid-159 
phase extraction (SPE). One laboratory blank was created for each sampling event. 160 
 161 
2.4. Solid-phase extraction 162 
Upon arrival by courier, the pH of the samples was finely adjusted to 2 using HCl (12 M), 163 
stored at 4ºC and extracted within 24 h. Samples were vacuum filtered through 2 µm glass 164 
fibre filters (47 mm diameter; Millipore, VIC). Each 1 L bottle of sample was passed through 165 
a preconditioned SPE cartridge (Waters Oasis HLB SPE cartridges; 500 mg sorbent, 6 cc; 166 
Waters, NSW) at 10 mL/min. Conditioning consisted of 10 mL of acetone: hexane (1:1), 167 
followed by 10 mL methanol, and finally 10 mL ultrapure water. After passing the full water 168 
sample, the SPE cartridges were dried under vacuum at 20 mmHg for 2 h (or until dry). Dried 169 
cartridges were wrapped in aluminium foil and stored at 4ºC (for up to 2 weeks) until elution. 170 
The polar fraction was eluted with 10 mL methanol and the non-polar fraction was eluted 171 
with 10 mL acetone: hexane (1:1). The fractions from replicate cartridges were combined and 172 
evaporated under nitrogen until dry and immediately reconstituted in 1 mL methanol for 173 
analysis. Reconstituted samples were split into 2 × 500 µL aliquots; one for bioassay analysis 174 
and the other for chemical analysis.  175 
 176 
2.5. Chemical analysis 177 
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The industrial compounds bisphenol A and 4-t-octylphenol were analysed based on the 178 
method of Vanderford and Snyder (2006). Transitions can be found in Table S1. Hormones 179 
were analysed by Gas Chromatrography - Tandem Mass Spectrometry (GC-MS/MS) as 180 
previously described in Trinh et al. (2011). 181 
Standard solutions of all analytes were prepared at 1, 5, 10, 50, 100, 500 and 1000 ng/mL. A 182 
relative response ratio of analyte/ internal standard over a 1–1000 ng concentration range was 183 
generated enabling quantitation with correction for losses due to ion suppression. All 184 
calibration curves had a correlation coefficient of 0.99 or better. Limits of detection (LODs) 185 
were defined as the concentration of an analyte giving a signal to noise ratio greater than 3. 186 
The limits of quantification (LOQs) were determined using a ratio of greater than 10.   187 
 188 
2.6. Ethinylestradiol analysis by ELISA 189 
To improve on the GC-MS/MS quantification limit for ethinylestradiol (EE2) of 1 ng/L, a 190 
commercially available ELISA (enzyme-linked immunosorbent assay) method was modified 191 
to achieve a lower quantification limit. EE2 ELISA kits were purchased from Biosense 192 
Laboratories (Norway) and originally sourced from Takiwa Chemical Industries (Japan). In 193 
order to decrease the LOQ, standards were first diluted 10× with deionized water, a 194 
concentration that still produced a repeatable and concentration-dependent response. Samples 195 
were tested twice on different days, and standard curves were generated in duplicate. The 196 
LOQ for the full method including sample enrichment by SPE was 0.05 ng/L EE2. 197 
 198 
2.7. CALUX bioassays 199 
The ERα-, AR- and PR-CALUX bioassays were conducted using previously published 200 
methods (Legler et al. 1999; Sonneveld et al. 2011, 2005) with slight modifications noted in 201 
Leusch et al. (2010). Luminescence was read in a FLUOstar Omega Spectrometer (BMG 202 
Labtech, Germany). 203 
 204 
2.8. Data analysis and statistics 205 
 19 
As is often the case with environmental studies, our dataset was heavily left censored with a 206 
large proportion of non-detects. Non-detections were assigned a value of half of the LOQ for 207 
calculation of averages and standard error of mean (SEM) for graphic and tabular purposes. 208 
Kruskal-Wallis nonparametric test followed by Dunn’s multiple comparison test (p<0.05) 209 
were used to determine significant differences in estrogenic and anti-progestagenic activity 210 
based on catchment land-use categories. All statistics were performed using Prism 5 software 211 
(GraphPad Software, La Jola, CA, USA).  212 
 213 
3. Results and Discussion 214 
3.1. Estrogenic and anti-estrogenic activity 215 
Nineteen percent of all samples (53) had quantifiable estrogenic activity (>0.1 ng/L EEQ; Fig. 216 
2 top), with 2% of samples (7) above 1 ng/L EEQ. The detection frequency was highest in 217 
residential samples (27%), followed by industrial (25%), agricultural (20%), WWTP (14%) 218 
and undeveloped land (6%). The highest estrogenic activity was detected downstream of a 219 
WWTP discharge, at 6.5 ng/L EEQ. Anti-estrogenic activity was not detected in any water 220 
samples using the ERα-CALUX assay (LOQ = 5 µg/L tamoxifen equivalent, TMXEQ). 221 
Our estrogenic results are comparable to those previously obtained in Australia (Table 1) and 222 
other industrialized countries. For example, a Dutch study reported 0.2 - 0.5 ng/L EEQ in 223 
surface waters using the ERα-CALUX (van der Linden et al. 2008), while a US study 224 
calculated a maximum activity of 1.5 ng/L EEQ based on a pharmaceutical assessment and 225 
transport evaluation (PhATE) (Anderson et al. 2012). Those concentrations are much lower 226 
than what has been reported in a study comparing eight Asian countries, with predicted 227 
estrogenic activities of 4 - 46 ng/L EEQ in surface waters based on chemical concentrations 228 
(Duong et al. 2010).229 
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Fig. 2. Average estrogenic activity (17β-estradiol equivalent, EEQ) measured with the 230 
estrogen receptor CALUX assay (top) and anti-progestagenic activity (mifepristone 231 
equivalent, MifEQ) measured with the progesterone receptor CALUX (bottom) of 285 unique 232 
extracts from riverine water samples collected quarterly throughout a 1-year period. Water 233 
samples separated based on predominant local land-use. Error bars represent the standard 234 
error of the mean, with non-detects assigned a value of half the limit of quantification. Points 235 
represent values above the mean. "LOQ" = limit of quantification; "DL" = detection limit. * 236 
p<0.05 (Kruskal-Wallis nonparametric test followed by Dunn’s multiple comparison test). 237 
 238 
239 
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There is still some uncertainty as to what constitutes an unsafe level of estrogenic activity in 240 
river water. Using a predicted no effect concentration (PNEC) for 17β-estradiol of 1 ng/L 241 
(Young et al. 2004) translates into 1 ng/L EEQ in the ERα-CALUX. In our study, seven 242 
samples exceeded 1 ng/L EEQ, indicating potential estrogenic effects in exposed aquatic 243 
organisms at those sites. None of the samples exceeded 1 ng/L at the same site in subsequent 244 
sampling events, which suggests that high estrogenicity was not a persistent condition. 245 
However, low-level estrogenicity was detected more than once at each of the seven sites. 246 
With one exception, the high estrogenic results occurred in the spring (Nov 2011) and 247 
summer (Feb 2012) samples. There was no clear land-use activity associated with these seven 248 
high estrogenic results, with three residential, two agricultural, one industrial and one WWTP 249 
samples above 1 ng/L EEQ. These results emphasize the need to monitor the aquatic 250 
receiving environments more widely and not merely focus on sites downstream of WWTP. 251 
Jarosova et al. (2013) derived bioassay-based short-term and long-term safe EEQs (EEQ-252 
SSE) that, when exceeded, indicate a potential in vivo hazard. For the ER-CALUX bioassay, 253 
the proposed EEQ-SSEs were 0.2 - 0.4 ng/L EEQ for long-term and 0.6 - 2 ng/L EEQ for 254 
short-term exposures (Jarosova et al. 2013). All 53 estrogenic samples in this study exceeded 255 
the most conservative long-term EEQ-SSE (0.2 ng/L EEQ). In more detail, 18 sites had 256 
measurable estrogenicity in only one sample (0.3 - 0.9 ng/L EEQ), while nine sites had two 257 
positive samples (0.3 - 6.5 ng/L EEQ). The most conservative short-term EEQ-SSE (0.6 ng/L 258 
EEQ) was applied resulting in 19 exceedances at 16 sites; the least conservative short-term 259 
EEQ-SSE (2 ng/L EEQ) resulted in only one exceedance. Three sites had estrogenicity in 260 
three out of four samples (0.2 - 1.2 ng/L EEQ) and two sites had activity in all four samples 261 
(0.3 - 2.6 ng/L EEQ). All of these sites exceeded the long-term EEQ-SSE at least once, 262 
regardless of what value was applied. In total, 25 samples were above 0.6 ng/L EEQ and two 263 
were above 2 ng/L EEQ. 264 
Most of the estrogenic samples in this study had activities between 0.1 and 1 ng/L EEQ. This 265 
level of estrogenic activity presents a low risk when compared to the PNEC for 17β-estradiol, 266 
but special consideration needs to be given to EE2. Indeed, while EE2 is almost equipotent to 267 
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17β-estradiol in vitro (Legler et al. 2002), it is 10× more potent in vivo and subsequently has a 268 
PNEC of 0.1 ng/L (Young et al. 2004; Caldwell et al. 2012). As such, a sample with an EEQ 269 
as low as 0.1 ng/L may still be of environmental concern if all that activity is caused by EE2 270 
(at 0.1 ng/L). For this reason, all estrogenic samples above 0.1 ng/L EEQ were re-analysed 271 
using a more sensitive ELISA method. More than half of all estrogenic samples (28 out of 53) 272 
had quantifiable EE2 concentrations (>0.05 ng/L), clearly illustrating that estrogenic activity 273 
in river water samples was often associated with the presence of EE2. Almost a quarter (13) 274 
of all estrogenic samples had EE2 concentrations above the PNEC of 0.1 ng/L (up to 0.17 275 
ng/L), which is cause for concern, although it should be noted that the sporadic EE2 276 
detections were still at least an order of magnitude lower than the sustained 2-5 ng/L 277 
concentration required to cause significant ecological disruption (Kidd et al. 2007), and thus 278 
any estrogenic effect is likely to be mild.  279 
To determine the relevance and contribution of the monitored chemicals to the estrogenic 280 
activity in the water samples, we compared predicted estrogenicity vs. measured estrogenicity 281 
in the ERα-CALUX bioassay. Predicted estrogenicity was calculated for each sample as the 282 
sum of the product of the concentration of each compound (Table 4) and its potency in the 283 
ERα-CALUX assay (Table 3). In most cases, measured estrogenicity was in good agreement 284 
with predicted estrogenicity, falling within an order of magnitude of the isometric line (i.e., 285 
between the parallel dashed lines on Fig. 3). Only five of the 53 estrogenic samples (measured 286 
estrogenicity ≥0.1 ng/L EEQ) were clearly more biologically active than would be expected 287 
from chemical analysis alone, indicating either the presence of estrogenic chemicals below 288 
the chemical LOQs or unknown estrogenic compounds. There was also good agreement for 289 
most (97%) of the 232 samples that did not produce significant estrogenicity in the ERα-290 
CALUX bioassay (data not shown), with measured and predicted estrogenicity in agreement 291 
at <0.1 ng/L EEQ. Only eight of those samples had predicted activity higher than 0.1 ng/L 292 
EEQ (up to 0.25 ng/L EEQ; grey data points in Fig. 3), with estrone as the only driver of the 293 
calculated estrogenicity in all cases. This may indicate the presence of anti-estrogenic 294 
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compounds in those samples, which would reduce the total estrogenic activity as measured in 295 
the bioassay.296 
 24 
Fig. 3. Comparison of estrogenic activity (17β-estradiol equivalent; EEQ) measured in vitro 297 
using the ERα-CALUX assay versus predicted estrogenic activity based on chemical analysis 298 
and relative potencies of compounds in the assay (Table 2). Limit of quantification = 0.1 ng/L 299 
EEQ. Grey data points were predicted to have estrogenicity, but none was detected. White 300 
circle represents samples with neither measured, nor predicted estrogenicity. 301 
302 
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Table 3. Relative potencies of chemicals monitored in this study in the CALUX bioassays. "NA" = Not available; "Neg" = Negative in this assay; "RP" = 303 
relative potency. Adapted from Leusch et al. 2014a, except for PR-CALUX antagonistic potencies, and others noted. 304 
  Potency in ERα-CALUX Potency in AR-CALUX  Potency in PR-CALUX  
  Agonistic (RP rel to 
17β-estradiol; 
Antagonistic (RP 
rel to tamoxifen; 
Agonistic (RP rel to 
DHT; 
Antagonistic (RP 
rel to flutamide; 
Agonistic (RP rel to 
levonorgestrel; 
Antagonistic (RP 
rel to mifepristone; 
EC50 = 1.5E-12M) EC50 =2.5E-08M) EC50 =3.6E-10M) EC50 =9.2E-07M) EC50 =3.1E-10M) EC50 =2.4E-08M) 
Steroids hormones             
   Androstenedione Neg (<0.03)
a
 NA
d
 0.058
a
 NA
d
 Neg (<0.02)
a
 Neg (<3.6E-06) 
   Androsterone Neg (<0.03)
a
 NA 0.0056
a
 NA Neg (<0.02)
a
 Neg (<2.7E-06) 
   Dihydrotestosterone (DHT) 1.50E-05 Agonist 1.0 Agonist 5.20E-06 0.0020 
   17α-Estradiol (αE2) 0.002 Agonist Neg (<5.5E-06) 14 Neg (<8.3E-06) 0.0014 
   17β-Estradiol (βE2) 1.0 Agonist 3.98E-05 72 Neg (<6.3E-06) 0.0031 
   Estriol (E3) 0.017 Agonist Neg (<6.2E-06) 0.55 Neg (<1.8E-05) 0.0016 
   Estrone (E1) 0.014 Agonist Neg (<2.7E-05) 15 Neg (<4.2E-05) 0.0036 
   17α-Ethinylestradiol (EE2) 5.4 Agonist Neg (<6.0E-06) 91 4.1E-05 0.0035 
   Etiocholanolone NA NA NA NA NA 0.0021  
   Levonorgestrel 2.90E-06 Agonist 0.37
b
 NA
b
 1.0 Agonist 
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   Mestranol 6.20E-04 Agonist Neg (<1.6E-05) 2 Neg (<1.9E-05) 9.60E-04 
   Testosterone 1.70E-06 Agonist 0.17 Agonist Neg (<1.6E-05) 6.00E-04 
Industrial Compounds             
   Bisphenol A (BPA) 1.40E-05 Agonist Neg (<4.6E-06) 0.21 Neg (<7.1E-06) 6.20E-04 
   4-t-octylphenol (4-t-OP) 1.20E-05 Agonist Neg (<4.2E-06) 0.41 Neg (<1.9E-05) 5.50E-04 
Notes: 
a
 Houtman et al. 2009; 
b
 van den Burg et al. 2010; 
c
 Sonneveld et al. 2011; 
d
 Sonneveld et al. 2005. 305 
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Table 4. Chemical monitoring data of known, detected endocrine active compounds in 285 306 
individual water extracts separated by dominant land-use impact at sample location. SEM = 307 
standard error of the mean. WWTP=waste water treatment plant. 308 
  309 
  Count Detects Mean ± SEM Median 95th Percentile Max 
(n) (n) (ng/L) (ng/L) (ng/L) (ng/L) 
Steroids and 
Hormones 
            
   Androstenedione             
      Agricultural 80 0 <5 <5 <5 <5 
      Industrial 28 0 <5 <5 <5 <5 
      Residential 74 1 <5 <5 <5 28 
      WWTP 50 5 <5 <5 20 36 
      Undeveloped 53 0 <5 <5 <5 <5 
   Androsterone             
      All land-uses 285 0 <1 <1 <1 <1 
   Dihydrotestosterone           
      All land-uses 285 0 <16 <16 <16 <16 
   17α-Estradiol             
      Agricultural 80 1 <1 <1 <1 4 
      Industrial 28 0 <1 <1 <1 <1 
      Residential 74 0 <1 <1 <1 <1 
      WWTP 50 0 <1 <1 <1 <1 
      Undeveloped 53 0 <1 <1 <1 <1 
   17β-Estradiol             
      All land-uses 285 0 <1 <1 <1 <1 
   Estriol             
      All land-uses 285 0 <3 <3 <3 <3 
   Estrone             
 28 
      Agricultural 80 20 2 ± 0.3 <1 8 18 
      Industrial 28 4 3 ± 2.0 <1 5 57 
      Residential 74 24 3 ± 0.8 <1 10 57 
      WWTP 50 16 2 ± 0.5 <1 7 22 
      Undeveloped 53 14 1 ± 0.3 <1 3 10 
   17α-Ethinylestradiol           
      Agricultural 80 10 <0.05 <0.05 0.09 0.17 
      Industrial 28 3 <0.05 <0.05 0.09 0.11 
      Residential 74 6 <0.05 <0.05 0.06 0.11 
      WWTP 50 6 <0.05 <0.05 0.09 0.16 
      Undeveloped 53 3 <0.05 <0.05 <0.05 0.12 
   Etiocholanolone             
      All land-uses 285 0 <6 <6 <6 <6 
   Levonorgestrel             
      All land-uses 285 0 <5 <5 <5 <5 
   Mestranol             
      All land-uses 285 0 <1 <1 <1 <1 
   Testosterone             
      All land-uses 285 0 <5 <5 <5 <5 
Industrial Compounds           
   Bisphenol A             
      Agricultural 80 46 25 ± 3 <20 83 114 
      Industrial 28 21 308 ± 154 65 1,055 4,130 
      Residential 74 56 131 ± 34 46 404 1,820 
      WWTP 50 33 34 ± 7 <20 121 251 
      Undeveloped 53 31 28 ± 6 <20 84 262 
   4-t-Octylphenol             
      Agricultural 60 2 <10 <10 <10 13 
      Industrial 21 4 12 ± 4 <10 38 81 
      Residential 55 11 <10 <10 27 49 
 29 
      WWTP 37 2 <10 <10 <10 11 
      Undeveloped 39 2 <10 <10 <10 29 
 310 
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While there was generally good agreement, predicted estrogenic activity was typically less 311 
than the measured activity (in 30 of the 53 estrogenic samples; Fig. 3). Most of those samples 312 
(83%) contained the industrial compounds bisphenol A (BPA) or 4-t-octylphenol (4-t-OP), or 313 
both. This hints at the likelihood that other industrial compounds, likely to co-occur with BPA 314 
and 4-t-OP, are present in concentrations that make up for the discrepancy between the 315 
predicted and the (higher) detected estrogenic activity (Fig. 3). One credible candidate is 4-316 
nonylphenol (4-NP); 4-t-OP and 4-NP are both long chain alkylphenols, and together with 317 
BPA, are used in a variety of industrial operations. 4-NP is also often used as a chemical 318 
marker for WWTP impacted water and various isomers of 4-NP are often found in 319 
conjunction with 4-t-OP (Zhang et al. 2012). Although 4-NP is a potent estrogenic EAC, it 320 
has over 550 possible isomers (Zhang et al. 2012) which were not quantified in this study. 321 
Often, technical NP (tNP), a mixture of 20-30 NP isomers (Eganhouse et al. 2009; Preuss et al. 322 
2006), is used as a standard for chemical and biological analysis of water samples. However, 323 
the biodegradation rate and estrogenic potency of each isomer is dependent on the isomeric 324 
composition of the NP molecule, and many isomers are present in impacted freshwater 325 
environments (Kim et al. 2005; Routledge and Sumpter 1997). Therefore, using a tNP or a 326 
mono-isomeric standard (such as 4-n-NP) for chemical and biological analysis will not yield 327 
accurate results. 4-n-NP was analysed in this study but was not detected in any of the samples, 328 
probably due to the rare presence of that specific isomer in environmental mixtures. Given the 329 
likelihood of 4-NP being present in water extracts containing industrial compounds such as 330 
BPA and 4-t-OP, it is probable that a substantial portion of the unaccounted estrogenic 331 
activity measured in the 25 samples that contained ether BPA or 4-t-OP, or both, is due to 4-332 
NP.  333 
 334 
3.2. Progestagenic and anti-progestagenic activity 335 
Progestagenic activity was not detected in any sample (all samples <5 ng/L levonorgestrel 336 
equivalent; LevoEQ). However, progestagenic activity was detected recently in Australian 337 
WWTP effluents at concentrations up to 5.4 ng/L LevoEQ (Leusch et al. 2014a). In a Dutch 338 
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study, an industrial sample (0.96 ng/L LevoEQ) and surface water sample (1.96 ng/L 339 
LevoEQ) had higher progestagenic activity compared to the two WWTP effluent samples 340 
(0.31 - 0.38 ng/L LevoEQ) (LevoEQ converted from Org2058 equivalents) (van der Linden et 341 
al. 2008). A lower detection limit may have detected progestagenic activity that was missed 342 
with the LOQ of 5 ng/L LevoEQ in this study. Anti-progestagenic activity (>8 µg/L 343 
mifepristone equivalent; MifEQ) was detected in 16% (45) samples. It was detected in more 344 
samples from industrial areas (50%) than other land-uses, such as residential (23%), 345 
downstream of WWTPs (13%), agricultural (6%) and undeveloped sites (4%) (Fig. 2 bottom). 346 
Anti-progestagenic activity was as high as 32 µg/L MifEQ at one industrial river site, 347 
however the average activity for all land-uses was <LOQ (8 µg/L MifEQ) due to the large 348 
number of samples below LOQ. Similar anti-progestagenic activity was measured in Chinese 349 
WWTP effluent (29 µg/L MifEQ, measured with a yeast based bioassay) (Li et al. 2011). 350 
The identity of the anti-progestagenic compound(s) is currently unknown. However, 4-NP 351 
and BPA at high concentrations have been shown to significantly inhibit the binding of 352 
progesterone to recombinant human progesterone receptor (Viswanath et al. 2008). They were 353 
also weakly antagonistic in the PR-CALUX assay (Table 3). Many steroid hormones (DHT, 354 
17α-estradiol, 17β-estradiol, estriol, estrone, EE2, etiocholanolone, mestranol and 355 
testosterone) also showed weak antagonistic properties in the PR-CALUX. However, for 356 
every anti-progestagenic sample (>8 µg/L), there was no predicted anti-progestagenic activity. 357 
As such, the causative anti-progestagenic compound(s) responsible for the measured activity 358 
is yet to be identified. 359 
BPA was found in 66% of samples across Australia from every land-use category (average = 360 
105 ng/L; Table 4), so further research focusing on its potential anti-progestagenic properties 361 
is warranted. The frequency of detection of BPA in this study correlates with other large-scale 362 
freshwater studies in the US (31 of 85 samples; 41%) (Kolpin et al. 2002) and The 363 
Netherlands (50 of 97 samples; 66%) (Vethaak et al. 2005). Furthermore, BPA, 4-t-OP and 4-364 
NP have been found together in a high frequency of samples from WWTP effluents and 365 
freshwater environments across the world, such as Switzerland (Ahel et al. 1994), China 366 
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(Wang et al. 2013), and France (Cladiere et al. 2013). Therefore, it is probable that some of 367 
the anti-progestagenic activity observed in this study is a result of the presence of 4-NP or 368 
other alkylphenols we have not been able to identify.  369 
 370 
3.3. Androgenic and anti-androgenic activity 371 
Androgenic activity was not detected in any of the samples using the AR-CALUX assay (all 372 
<7 ng/L dihydrotestosterone equivalent; DHTEQ), nor was it detected in 45 WWTPs in VIC 373 
(Allinson et al. 2008), or 4 WWTP effluents in WA (<2.5 ng/L dihydrotestosterone 374 
equivalents; DHT, measured with the AR-CALUX) (Leusch et al. 2014b). Coleman et al. 375 
(2008) measured androgenic activity in primary and tertiary WWTP effluents at up to 8.9 376 
ng/L testosterone equivalents (TEQ) using the Yeast Androgen Screen (YAS) assay, while 377 
Leusch et al (2006b) measured androgenicity in 15 WWTPs located in QLD with a maximum 378 
activity of 736 ng/L testosterone equivalents (TEQ) using the androgen receptor binding 379 
assay (ARBA). Another Australian study quantified androgenicity up to 2 ng/L DHTEQ using 380 
the AR-CALUX (Leusch et al. 2014a). A Dutch study reported up to 12 ng/L DHTEQ in 381 
surface water using the AR-CALUX assay, with the highest concentrations in industrial and 382 
hospital wastewater (up to 86 ng/L DHTEQ) and only modest concentrations in WWTP 383 
effluents (up to 0.8 ng/L DHTEQ) (van der Linden et al. 2008). 384 
Anti-androgenic activity was only quantifiable in a handful (2%) of samples (>60 µg/L 385 
flutamide equivalent; FluEQ). Four residential and 3 industrial samples had anti-androgenic 386 
activity ranging from 70 - 257 µg/L FluEQ (data not shown). Predicted anti-androgenic 387 
activity based on known potencies (Table 3) and EAC concentrations (Table 4) did not 388 
correlate with measured activity, indicating the presence of unknown anti-androgenic EACs. 389 
Estrone is a strong anti-androgen in the AR-CALUX, 15× more potent than flutamide (Table 390 
3), but with a maximum concentration of 57 ng/L (Table 4), the anti-androgenic activity due 391 
to estrone would still only amount to 0.9 µg/L FluEQ (well short of the LOQ of 60 µg/L 392 
FluEQ). This also applies to BPA and 4-t-OP. Regardless, their detection most likely 393 
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indicates the presence of other industrial compounds that may have more potent anti-394 
androgenic properties. 395 
Of the seven anti-androgenic samples, six were also anti-progestagenic (Fig. 4). The presence 396 
of BPA in each of these samples (62 - 1,820 ng/L) could again correlate with the presence of 397 
other unknown industrial compounds with possible endocrine activity, accounting for the 398 
remaining anti-androgenic and anti-progestagenic activity. 399 
 400 
3.4. Samples with multiple endocrine activities 401 
In total, 82 samples produced a biological response in any of the six endpoints measured 402 
(ERα+, ERα-, AR+, AR-, PR+ and PR-). The majority of those samples (57 out of 82) 403 
produced a biological response in only one endpoint. Twenty-one samples produced a 404 
response in two in vitro assays, and two samples produced activity in three different assays 405 
(Fig. 4). It is well known that certain EACs can affect multiple endocrine functions (e.g. BPA; 406 
Table 3). Therefore, it is possible that yet-identified EACs having multiple endocrine effects 407 
are present, for example in some of the 16 samples that were both estrogenic and anti-408 
progestagenic.409 
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Fig. 4. Ven diagrams depicting samples with quantifiable endocrine activity. ERα-CALUX 410 
limit of quantification (LOQ) = 0.1 ng/L 17β-estradiol equivalent (EEQ). Anti-AR-CALUX 411 
LOQ = 60 µg/L flutamide equivalent (FluEQ). Anti-PR-CALUX LOQ = 8 µg/L mifepristone 412 
equivalent (MifEQ). Anti-estrogenic, progestagenic and androgenic activities were not 413 
detected in any samples (LOQ = 5 µg/L tamoxifen equivalent, 0.5 ng/L levonorgestrel 414 
equivalent, and 7 ng/L dihydrotestosterone equivalent, respectively). 415 
 416 
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3.5. Chemical analysis of EACs  417 
Most samples (88%) had a detectable concentration of at least one of the 14 EACs monitored; 418 
however, on average, only a handful of the 14 EACs monitored were detected in each sample, 419 
with 1.3 compounds detected on average in residential samples, 1.2 in samples downstream of 420 
WWTP discharges, 1.1 in industrial samples, and 0.9 each in agricultural and undeveloped 421 
samples. The maximum number of EACs detected in one sample was four, in a sample 422 
collected downstream of a WWTP. 423 
Estrone was the most abundant hormone measured in this study (detected in 27% of samples) 424 
with a maximum concentration of 57 ng/L in an industrial sample and a residential sample, 425 
both from NSW (Table 4). Estrone was most frequently detected in residential samples and 426 
WWTP samples (32% of all samples in each land-use), followed by undeveloped (26%), 427 
agricultural (25%) and industrial samples (14%). Estrone detection frequencies did not differ 428 
greatly among states but was higher in this study (27%) compared to a US survey (7%) 429 
(Kolpin et al. 2002). The concentrations of estrone detected in this study were comparable but 430 
slightly higher than most previously reported in Australian rivers and wastewater (Table 1) 431 
and other studies (Young et al. 2004), but markedly lower than the maximum concentration of 432 
112 ng/L found in a US stream (Kolpin et al. 2002). A PNEC of 6 ng/L for estrone was 433 
derived by assessing vitellogenin induction in multiple fish species (Caldwell et al. 2012). Out 434 
of the 78 samples that had quantifiable estrone, 24 had concentrations at or above the PNEC 435 
indicating a potential hazard to fish at the corresponding sampling locations.  436 
EE2 has previously been discussed in some detail (see 3.1). Thirteen samples contained EE2 437 
at concentrations greater than its PNEC of 0.1 ng/L (Young et al. 2004; Table 4). Not 438 
surprisingly, these concentrations were lower than many Australian studies that measured 439 
EE2 in WWTP effluent (Table 1). EE2 concentrations were also lower in this study, 440 
compared to river samples taken downstream of WWTPs in other Australian studies (Ying et 441 
al. 2009; Ying et al. 2008; Table 1).  The maximum EE2 concentration was substantially 442 
lower in this study compared to that of a US study (0.17 ng/L vs. 831 ng/L), but the detection 443 
frequencies were similar (10% and 16%, respectively) (Kolpin et al. 2002). Surprisingly, 444 
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there was no clear correlation between the presence of EE2 and land-use category: the 13 445 
samples with EE2 concentration above 0.1 ng/L were evenly distributed among agricultural 446 
(four), residential (three), downstream of WWTPs (two), industrial (two) and undeveloped 447 
(two) sites. The existence of the synthetic hormone EE2, primarily used in human birth 448 
control pills, in this wide variety of land-use classes indicates the presence of human 449 
wastewater even when there is no clear WWTP input, an indication of leaking septic systems, 450 
sewage overflow or low-level but widespread wastewater contamination. Considering the 451 
very low PNEC for EE2, these results indicate that caution and further investigation is 452 
necessary.  453 
Of the other estrogen hormones, only 17α-estradiol was detected, and only in one agricultural 454 
sample (at 4 ng/L). 17β-Estradiol, estriol and mestranol were not detected above their LOQ (1, 455 
3 and 1 ng/L, respectively). While no samples in this study contained 17β-estradiol, a US 456 
survey reported its presence in 10% of surface water samples (Kolpin et al. 2002). 17β-457 
Estradiol is frequently detected in Australian wastewater (Table 1), but it has a comparatively 458 
short half-life in river water and is degraded to estrone (Jürgens et al. 2002), and thus likely 459 
contributes to the wide detection of estrone in our samples. 460 
Androgenic hormones were only occasionally detected. A maximum concentration of 36 ng/L 461 
for androstenedione was detected twice; once in a SA WWTP sample and once in a WA 462 
WWTP sample. Lower concentrations were also detected in three other WWTP samples and 463 
one residential sample (Table 4). Androsterone, DHT, etiocholanolone and testosterone were 464 
not detected in any sample (n=285) above their LOQ (1, 16, 6 and 5 ng/L, respectively). The 465 
only other Australian study measuring androgenic compounds in river samples did not find 466 
androsterone or etiocholanolone (Tan et al., 2007; Table 1). Androstenedione, androsterone, 467 
etiocholanalone and testosterone have been previously detected in Australian WWTP 468 
effluuents at maximum concentrations of 17, 67, 180 and 2.9 ng/L, respectively (Allinson et 469 
al. 2008; Leusch et al. 2014b; Table 1).  470 
The progestin levonorgestrel was not detected in any sample (LOQ=5 ng/L, n=285). 471 
Levonorgestrel, together with EE2, is an active ingredient in the birth control pill and so it is 472 
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surprising that it was not detected in this study. Two possible explanations are that it may be 473 
metabolized by the body more completely than EE2, or the chemical and in vitro LOQs (both 474 
5 ng/L) were simply not sensitive enough to detect levonorgestrel at the environmentally 475 
relevant concentrations. High blood plasma concentrations (up to 12 ng/mL) have been found 476 
in trout exposed to WWTP effluent (Fick et al. 2010) and concentrations as low as 0.8 ng/L 477 
can cause infertility in fathead minnow (Zeilinger et al. 2009). Further investigation using 478 
improved method detection limits is certainly warranted considering the occurrence of EE2 in 479 
several samples.  480 
With a maximum concentration of 4,130 ng/L in a NSW industrial sample and a detection 481 
frequency of 65%, the industrial compound BPA was the most prevalent EAC detected in the 482 
present study. BPA was present in 76% of residential samples, 75% of industrial samples, 483 
66% of WWTP samples, and 58% of agricultural samples and undeveloped samples (but was 484 
not detected in laboratory blanks). The concentration of BPA reported here was higher than 485 
what has previously been reported for Australia (Table 1). BPA was present at a higher 486 
frequency in Australian freshwater streams compared to that reported for US streams (65% vs. 487 
41%) and had a higher maximum concentration (4,130 ng/L vs. 1,900 ng/L) (Kolpin et al. 488 
2002). BPA concentrations were also considerably higher than those reported at a WWTP 489 
impacted canal in Greece (380 ng/L) (Arditsoglou and Voutsa 2008) or surface water in 490 
Germany (maximum BPA concentration of 410 ng/L) (Fromme et al. 2002). Canada has 491 
adopted a predicted no effect concentration (PNEC) of 175 ng/L for BPA (Environment 492 
Canada 2008), derived using a 103d exposure and measuring brown trout semen quality and 493 
delayed ovulation assay. In our study there were 24 samples with concentrations above 175 494 
ng/L. As such, BPA could be having a negative impact on fish reproduction at the 495 
corresponding sample locations.  496 
4-t-OP was detected in 21 samples with a maximum concentration of 81 ng/L. It was found 497 
frequently in residential samples (20 %). A PNEC of 330 ng/L, established by measuring 498 
chronic activity in Oryzias latipes (Japanese medaka) (Ministry of the Environment in Japan 499 
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2009), indicates that concentrations of 4-t-OP reported here are unlikely to be cause for 500 
concern.  501 
4-t-OP was detected 15 times in the spring sampling event, however it was only detected 502 
three times in both winter and summer, and was not detected in autumn. BPA was prevalent 503 
in the autumn, winter, and spring, with 47%, 58% and 71% detection frequencies, 504 
respectively, but it was only detected in 1% of samples from the summer sampling event. No 505 
other temporal trends between sampling events were identified for any of the other monitored 506 
chemicals (data not shown). 507 
 508 
3.6. Conclusions 509 
Most surface water samples collected in this study (88%) had detectable concentration of at 510 
least one of the 14 EACs monitored. Using in vitro bioassays, endocrine activity was detected 511 
in 28% of samples. Nineteen percent of samples had estrogenic activity >0.1 ng/L EEQ (7 512 
samples exceeding the in vitro PNEC of 1 ng/L EEQ), and more than half of those had 513 
detectable concentrations of EE2 (0.05-0.17 ng/L), indicating that EE2 often drives the 514 
estrogenic response. The PNEC of 0.1 ng/L for EE2 was exceeded in 2% of samples (seven 515 
out of 285), indicating a potential hazard to the aquatic environment. Surprisingly, there was 516 
no clear association between land-use and EE2 concentration, suggesting either leaking septic 517 
tanks, sewage overflow or low-level but widespread wastewater contamination. The 518 
conservative short-term EEQ-SSE (0.2 ng/L EEQ) proposed by Jarosava et al. (2013) was 519 
exceeded 19 times at 16 estrogenic sites (one to two estrogenic samples out of four). Five 520 
sites with consistent estrogenicity (three to four positive samples out of four) exceeded the 521 
highest long-term EEQ-SSE proposed (2 ng/L EEQ) at least once. Whether this has caused 522 
endocrine effects on the exposed aquatic life is yet unknown.  523 
Anti-progestagenic activity was detected in 16% of all samples; however, the causative 524 
compounds were not identified, and environmental implications are unknown. It is currently 525 
unknown if the anti-progestagenic activity (<8 - 32 µg/L MifEQ) is severe enough to cause 526 
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endocrine disruption in Australian native species, let alone species found throughout the 527 
world. 528 
While EACs were detected in most water samples, their concentrations were generally well 529 
below levels of concern. Only three compounds were measured above PNEC values: BPA, 530 
which was identified in 66% of all samples, exceeded its PNEC of 175 ng/L in 24 samples 531 
(8%); estrone, the most frequently detected hormone, exceeded its PNEC of 6 ng/L in 24 532 
samples (8%); and EE2, as previously discussed, exceeded its PNEC of 0.1 ng/L in seven 533 
samples (2%). The widespread presence of BPA, and to a lesser extent, 4-t-OP, suggests that 534 
4-NP is likely present in many samples, and contributing to measured estrogenic activity, 535 
despite not measured due to analytical complications. 536 
Very little information exists on the toxicology of these EACs on Australian native species, 537 
but based on the available PNECs it is clear that while the risk is low, endocrine disruption538 
 n may occur intermittently at a small number of sites in Australian rivers.  539 
 540 
3.7. Future work 541 
Follow-up studies are warranted to determine the sensitivity to EACs of Australian species, 542 
some of which are uniquely different from conventional laboratory test species with which 543 
PNECs are often derived. Studies should also investigate anti-progestagenic activity in 544 
various waters and identify the compounds responsible for the anti-progestagenic activity 545 
detected in surface waters in this study. Further research is also necessary to determine what 546 
compounds are contributing to the higher than predicted estrogenic activity, or suppressing 547 
the estrogenic activity (as was the case with a few of samples). Finally, while this study 548 
suggests there may be intermittent risks to receiving biota at a particularly affected sites, it is 549 
unclear what the chronic risk posed by EACs is. The peculiar Australian climate, with 550 
alternating periods of flood and drought in particular make this question difficult to answer. 551 
The use of passive sampling devices and field assessment of sessile life forms (such as small 552 
fish and invertebrates) may provide future insights into this important question.  553 
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